Literature DB >> 9397392

Objective and subjective time courses of recovery from motion sickness assessed by repeated motion challenges.

J F Golding1, J R Stott.   

Abstract

The aim of this study was to determine whether the time course of recovery of tolerance, as assessed objectively by rechallenge with motion, paralleled the subjective recovery from motion sickness. Subjects (n = 20) were exposed to 5 pairs of nauseogenic motion challenges in which the time interval between the end of the first and the start of the second of each pair ranged from 15 min to 2 h. The cross-coupled motion challenge had an incrementing profile of rotational velocity from 4 degrees to 92 degrees.s-1 in steps of 4 degrees.s-1 every 30 s, with 8 head movements per 30 s, of approximately 45 degrees, and was continued to the point of moderate nausea. Objective loss of tolerance decreased from 15 min to 60 min after the first challenge, but increased again at 2 h. By contrast, most individuals reported subjective recovery by 15 min to 30 min. It was concluded that there is an underlying effect of motion sickness that sensitizes the response to subsequent motion for a period of at least 2 h. This underlying objective effect can occur in the absence of subjective symptoms, has a slower time course than the subjective recovery from symptoms, and appears to be non-monotonic.

Entities:  

Keywords:  Non-programmatic

Mesh:

Year:  1997        PMID: 9397392

Source DB:  PubMed          Journal:  J Vestib Res        ISSN: 0957-4271            Impact factor:   2.435


  5 in total

Review 1.  Space motion sickness.

Authors:  James R Lackner; Paul Dizio
Journal:  Exp Brain Res       Date:  2006-10-05       Impact factor: 1.972

Review 2.  Brainstem processing of vestibular sensory exafference: implications for motion sickness etiology.

Authors:  Charles M Oman; Kathleen E Cullen
Journal:  Exp Brain Res       Date:  2014-05-18       Impact factor: 1.972

3.  Effects of visual flow direction on signs and symptoms of cybersickness.

Authors:  Alireza Mazloumi Gavgani; Deborah M Hodgson; Eugene Nalivaiko
Journal:  PLoS One       Date:  2017-08-04       Impact factor: 3.240

4.  Electrocortical therapy for motion sickness.

Authors:  Qadeer Arshad; Niccolo Cerchiai; Usman Goga; Yuliya Nigmatullina; R Ed Roberts; Augusto P Casani; John F Golding; Michael A Gresty; Adolfo M Bronstein
Journal:  Neurology       Date:  2015-09-04       Impact factor: 9.910

5.  Motion sickness: more than nausea and vomiting.

Authors:  James R Lackner
Journal:  Exp Brain Res       Date:  2014-06-25       Impact factor: 1.972

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.